U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 9 of 9 results

Status:
US Approved Rx (2019)
First approved in 1996

Class (Stereo):
CHEMICAL (ACHIRAL)



Tizanidine is a short-acting drug for the management of spasticity. Tizanidine is an agonist at a2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. In animal models, tizanidine has no ...
Status:
US Approved Rx (2020)
First approved in 1977

Class (Stereo):
CHEMICAL (ACHIRAL)



Cyclobenzaprine is a centrally-acting muscle relaxant which boosts levels of norepinephrine and binds to serotonin receptors in the brain to reduce spasm. Cytochromes P-450 3A4, 1A2, and, to a lesser extent, 2D6, mediate N-demethylation, one of the o...
Status:
US Approved Rx (2007)
First approved in 1977

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Baclofen (brand names Kemstro, Lioresal, and Gablofen) is a derivative of gamma-aminobutyric acid (GABA). Baclofen is a muscle relaxer and an antispastic agent and is used to treat muscle symptoms caused by multiple sclerosis, including spasm, pain, ...
Status:
US Approved Rx (1974)
First approved in 1974

Class (Stereo):
CHEMICAL (ACHIRAL)



Dantrolene is a drug which was approved by FDA for the treatment of chronic spasticity and malignant hyperthermia (a rare life-threatening clinical syndrome). Dantrolene effect was shown both in vivo and in vitro and proved to be mediated by interact...
Status:
US Approved Rx (2015)
First approved in 1962

Class (Stereo):
CHEMICAL (RACEMIC)



Metaxalone (marketed by King Pharmaceuticals under the brand name Skelaxin) is a muscle relaxant used to relax muscles and relieve pain caused by strains, sprains, and other musculoskeletal conditions. The mechanism of action of metaxalone in humans ...
Status:
US Approved Rx (1989)
First approved in 1959

Class (Stereo):
CHEMICAL (RACEMIC)



A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal condi...
Status:
US Approved Rx (2010)
First approved in 1958

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Chlorzoxazone is a centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain where it inhibits multisyna...
Status:
US Approved Rx (2016)
First approved in 1957

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Methocarbamol is a central muscle relaxant for skeletal muscles, used to treat spasms. It is structurally related to guaifenesin. Methocarbamol's exact mechanism of causing skeletal muscle relaxation is unknown. It is thought to work centrally, perha...
Status:
US Previously Marketed
First approved in 1958

Class (Stereo):
CHEMICAL (MIXED)



Cyclandelate is a vasodilator developed for the treatment of cardiovascular diseases. The drug was used in many countries for such diseases as intermittent claudication, arteriosclerosis obliterans, thrombophlebitis, nocturnal leg cramps, local frost...